- Hem
- Om universitetet
- Hitta person
- Karl Emauel Fryk
Karl Emauel Fryk
Anknuten till forskning
Avd för molekylär och klinisk medicin-
Cardiorespiratory fitness and the association with galectin-1 in middle-aged
individuals
Daniel Arvidsson, Vagner Ramon Rodrigues Silva, Orjan Ekblom, Elin Ekblom-Bak, Emanuel Fryk, Per-Anders Jansson, Mats Börjesson
PLOS ONE - 2024 -
Galectin-1 correlates with inflammatory markers and T regulatory cells in children with type 1 diabetes and/or celiac
disease
Emanuel Fryk, Asa Wilsson, Andrea Tompa, Per-Anders Jansson, Maria Faresjo
CLINICAL AND EXPERIMENTAL IMMUNOLOGY - 2024 -
Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): a single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2
trial
Emanuel Fryk, Vagner Ramon Rodrigues Silva, Marco Bauzá-Thorbrügge, M. Schmelz, Li-Ming Gan, Lena Strindberg, Per-Anders Jansson
Eclinicalmedicine - 2023 -
Somatic ablation of IKKβ in liver and leukocytes is not tolerated in obese mice but hepatic IKKβ deletion improves fatty liver and insulin
sensitivity.
Vagner Ramon Rodrigues Silva, Angela Molinaro, Andrea Usseglio Gaudi, Emanuel Fryk, Claudia Sardi, Maria Hammarlund, Filip Mjörnstedt, Maria E Johansson, Barbara Becattini, Per-Anders Jansson, Giovanni Solinas
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 2022 -
The role of the platelet pool of Plasminogen Activator Inhibitor-1 in well-controlled type 2 diabetes
patients
Karin Mossberg, Josefin Olausson, Emanuel Fryk, Sverker Jern, Per-Anders Jansson, Helén Brogren
Plos One - 2022 -
The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation
analyses
I. Drake, Emanuel Fryk, Lena Strindberg, Annika Lundqvist, Anders H. Rosengren, L. Groop, E. Ahlqvist, Jan Borén, M. Orho-Melander, Per-Anders Jansson
Diabetologia - 2022 -
Galectin-1 in Obesity and Type 2
Diabetes
Emanuel Fryk, Vagner Ramon Rodrigues Silva, Per-Anders Jansson
Metabolites - 2022 -
The role of galectin-1 in type 2 diabetes. Clinical and experimental
studies
Emanuel Fryk
2022 -
Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort
study
Emanuel Fryk, Josefin Olausson, Karin Mossberg, Lena Strindberg, M. Schmelz, Helén Brogren, L. M. Gan, S. Piazza, A. Provenzani, Barbara Becattini, L. Lind, Giovanni Solinas, Per-Anders Jansson
Ebiomedicine - 2021 -
Wide QRS-T angles are associated with markers of increased inflammatory activity independently of hypertension and
diabetes.
Mikael Sandstedt, Lennart Bergfeldt, Joakim Sandstedt, Annika Lundqvist, Emanuel Fryk, Per-Anders Jansson, Göran Bergström, Lillemor Mattsson Hultén
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc - 2020 -
Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes
patients
Emanuel Fryk, Jeanna Perman Sundelin, Lena Strindberg, Maria J Pereira, M. Federici, N. Marx, Helena Filipsson Nyström, M. Schmelz, Per-Arne Svensson, Jan W Eriksson, Jan Borén, Per-Anders Jansson
Metabolism-Clinical and Experimental - 2016